Nurix Therapeutics, Inc. · NASDAQ:NRIX
Perceptive Advisors LLC's stake in Nurix Therapeutics, Inc. fell to 4.90% (Schedule 13G/A)
Event Sep 30, 2026 · Filed Nov 16, 2026
Perceptive Advisors LLC's stake in Nurix Therapeutics, Inc. fell to 4.90%, 5,371,629 shares, as a passive investor on Sep 30, 2026. Filed Nov 16, 2026 (Schedule 13G/A).
- Stake
- 4.90%
- Shares
- 5,371,629
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Perceptive Advisors LLC | 4.90% | 5,371,629 |
| Joseph Edelman | 4.90% | 5,371,629 |
| Perceptive Life Sciences Master Fund, Ltd. | 4.90% | 5,371,629 |
Source
Download original · View original at SEC
Related
- Nurix Therapeutics, Inc.
- Perceptive Advisors LLC
- Nurix Therapeutics, Inc. shareholders
- Schedule 13G · Perceptive Advisors LLC · Sep 23, 2026
- Schedule 13G/A · Rubric Capital Management LP · Nov 16, 2026
- Schedule 13G/A · Deep Track Capital, LP · Nov 16, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · Nov 16, 2026
- Schedule 13G/A · Vestal Point Capital, LP · Nov 16, 2026
- Schedule 13G/A · FMR LLC · Nov 5, 2026